In the last ten years, there has been an explicit characterization of the landscape of genetic changes in HCC (Zucman-Rossi et al., 2015), and TP53 is one of the most commonly mutated genes in HCC. This evidence concerns the gene TP53 and hepatocellular carcinoma.